This release shows that management have addressed shareholders (me) concerns about the information accompanying the rent resume announcement. Having said that I am not sure that this information paints a compelling picture.
1) ARPU: The 230% increase in 12 months is excellent but has flat lined in over the last 3 months. Currently generating ~ $1m p.a from product sales. Not bad but not enough. Assuming this grows at at RR rate 45k Qtr and ARPU $ grows at 10% QoQ this product revenue will grow to ~ $5m over the next 10 years. Not enough to make a really generate significant EBITDA and FCF.
So what else to have coming down line is a really important question that management needs to answer quickly.
2) Cash will run out in Q3 or Q4. Again assuming overall 10% growth rates for all income and no change to current expenses company will need > $8.5m of capital to get it through to a cash flow positive position. If Raised at $0.05 per share this will dilute existing shares by ~ 46% or put another you will have to cough up an additional 46% on top of your current holdings just for your equity position to stand still.
3) Running all this though my valuation models spits out $0.02 per share after raise. I must stress this is not a some mindless prediction. It just a model and in my experience all models are wrong. It does however point to some downside risk building up in this stock.
Positives: Management
Negatives: Revenue Growth
- Forums
- ASX - By Stock
- RNT
- RNT is falling
RNT is falling, page-7
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.35M |
Open | High | Low | Value | Volume |
2.3¢ | 2.3¢ | 2.2¢ | $8.907K | 390.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 262647 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 173262 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 327598 | 0.017 |
3 | 139228 | 0.016 |
9 | 948115 | 0.015 |
3 | 445000 | 0.014 |
3 | 191615 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 345544 | 1 |
0.019 | 168070 | 4 |
0.020 | 2702 | 1 |
0.021 | 382000 | 3 |
0.022 | 18333 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
RNT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online